Tier 2 services provide structured lifestyle and behavioural support, whilst Tier 3 specialist obesity services offer more intensive multidisciplinary input and can assess suitability for licensed pharmacotherapy or bariatric surgery
7,8 With the rising global prevalence of diabetes driven by aging populations and lifestyle changes, the impact of DN is expected to escalate
The two organizations also point out that semaglutide has previously been linked to other vision changes, such as blurred vision, worsening of diabetic retinopathy and macular complications, though these effects typically subside within three or four months
Abstract Glucagon-like peptide 1 (GLP1) receptor (GLP1R) agonists and tirzepatide, a dual GLP1R and glucose-dependent insulinotropic polypeptide receptor agonist, have become fundamental in managing type 2 diabetes mellitus (T2DM) and obesity due to their potent glycaemia-lowering and weight-lowering effects as well as their cardiovascular and renal benefits
It helps to know what to expect, so you can be prepared